Difficulty: Medium
Average Score: 90%
Practice
Which mechanism of action or pharmacological action is best associated with sitagliptin (januvia) and saxagliptin (onglyza)?
Correct answer
D
Rationale
Step-by-step rationale:
1. Sitagliptin and saxagliptin are both DDP-4 inhibitors.
2. DDP-4 inhibitors work by blocking the enzyme DDP-4, which degrades incretin hormones.
3. Incretin hormones increase insulin release and decrease glucagon secretion.
4. This results in improved blood sugar control in patients with type 2 diabetes.
Summary:
A: Binds PPAR-Gamma - Incorrect, as sitagliptin and saxagliptin do not bind PPAR-Gamma.
B: Decreases insulin resistance - Incorrect, as DDP-4 inhibitors primarily work on incretin hormones.
C: Increases insulin sensitivity - Incorrect, as the main action of DDP-4 inhibitors is through incretin hormones, not directly on insulin sensitivity.
1. Sitagliptin and saxagliptin are both DDP-4 inhibitors.
2. DDP-4 inhibitors work by blocking the enzyme DDP-4, which degrades incretin hormones.
3. Incretin hormones increase insulin release and decrease glucagon secretion.
4. This results in improved blood sugar control in patients with type 2 diabetes.
Summary:
A: Binds PPAR-Gamma - Incorrect, as sitagliptin and saxagliptin do not bind PPAR-Gamma.
B: Decreases insulin resistance - Incorrect, as DDP-4 inhibitors primarily work on incretin hormones.
C: Increases insulin sensitivity - Incorrect, as the main action of DDP-4 inhibitors is through incretin hormones, not directly on insulin sensitivity.